Table 5. The acquired gene mutations in the 5 patients (patient 2–6) that had NGS both at baseline and after transformation.
Acquired gene mutations | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 |
---|---|---|---|---|---|
WNK1 APC KMT2C ATRX PIAS4 SRP68 TERT LMNA CBLB RNF139 PTPRT MALT1 CFTR CRLF2 AMER1 TOP2A SLC47A2 BCLAF1 ZMYM3 HSP90AA1 EGFR Copy number gain | X | ||||
KIT | X | ||||
PPARG CD22 BCL6 | X | ||||
ZRSR2 FOXO1 KDR SMAD4 RANBP2 | X | ||||
RPTOR ABL2 IRS2 KLHL6 PDGFRB GNAS AURKA PTCH1 SMAD2 FLT3 KDM5A | X |
NGS, next-generation sequencing.